A New Orleans biotechnology company has reported that it found a previously unknown anti-polymer antibody in the blood of many fibromyalgia patients. The research, led by Russell B. Wilson, PhD, president of Autoimmune Technologies, used a patented blood test to identify the antibodies in about half of patients who were diagnosed with fibromyalgia. The percentage was somewhat higher in more severely ill fibromyalgia patients and lower in persons diagnosed with diseases such as rheumatoid arthritis, lupus and scleroderma.
In a press release, the company touted the finding as a potential marker for fibromyalgia, but independent researchers responded more cautiously, noting that more research is needed to confirm the specificity of the test. The research itself was published in the February 1999 issue of The Journal of Rheumatology.